Santersus AG Receives Second U.S. FDA Breakthrough Device Designation for NucleoCapture™ in Systemic Lupus Erythematosus August 27, 2025
Santersus AG Wins National Abstract Award at UK ECPR Summit for Groundbreaking Research in Critical Care September 26, 2024